Campbell Capital Management’s ResMed RMD Stock Holding History

Campbell Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-800	Closed	-$219K	–	55
2025 Q3	$219K	Hold	800	–	–	0.08%	42
2025 Q2	$206K	Hold	800	–	–	0.08%	49
2025 Q1	$179K	Hold	800	–	–	0.1%	30
2024 Q4	$183K	Buy	+800	New	+$193K	0.07%	44
2024 Q3	–	Sell	-1,600	Closed	-$306K	–	54
2024 Q2	$306K	Hold	1,600	–	–	0.13%	44
2024 Q1	$317K	Hold	1,600	–	–	0.14%	41
2023 Q4	$275K	Buy	+1,600	New	+$246K	0.13%	40
2023 Q2	$350K	Hold	1,600	–	–	0.2%	41
2023 Q1	$350K	Hold	1,600	–	–	0.27%	30
2022 Q4	$333K	Hold	1,600	–	–	0.34%	22
2022 Q3	$349K	Hold	1,600	–	–	0.32%	23
2022 Q2	$335K	Hold	1,600	–	–	0.36%	17
2022 Q1	$388K	Hold	1,600	–	–	0.22%	31
2021 Q4	$417K	Hold	1,600	–	–	0.17%	41
2021 Q3	$422K	Hold	1,600	–	–	0.19%	41
2021 Q2	$394K	Hold	1,600	–	–	0.18%	45
2021 Q1	$310K	Hold	1,600	–	–	0.14%	45
2020 Q4	$347K	Sell	1,600 -500	-24%	-$99.7K	0.17%	43
2020 Q3	$360K	Buy	2,100 +500	+31%	+$92.3K	0.21%	37
2020 Q2	$307K	Hold	1,600	–	–	0.21%	33
2020 Q1	$236K	Hold	1,600	–	–	0.24%	32
2019 Q4	$248K	Hold	1,600	–	–	0.15%	54
2019 Q3	$216K	Buy	+1,600	New	+$210K	0.16%	43

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Campbell Capital Management's RMD Position: Q4 2025 in Review

Campbell Capital Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 800 shares — an estimated $219K sold.

Campbell Capital Management first reported a position in RMD in Q3 2019 and held it in 23 quarters. The position peaked at $422K in Q3 2021. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

Campbell Capital Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
Campbell Capital Management sold 800 ResMed shares in Q4 2025, an estimated $219K.
Campbell Capital Management first reported a position in ResMed in Q3 2019 and held it in 23 quarters.
Campbell Capital Management's ResMed position peaked at $422K in Q3 2021.
947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Campbell Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.